(Q46851379)
Statements
A phase II dose-ranging study of sitamaquine for the treatment of visceral leishmaniasis in India (English)
Shyam Sundar
1 reference
Tara K Jha
Chandreshwar P Thakur
J Mark Felton
Antony J Sabin
John Horton